
David Anderson
Contact Info
Office Hours
- Today
- -
David Anderson
About David Anderson
David F. Anderson
FRCOphth FEBO FWCRS PhD MB BS
• Founder Anderson Eye Care
• Cofounder Laser Vision Eye Centre
• Affiliate Member of the Institute for Life Sciences | University of Southampton
• Fellow of the World College of Refractive Surgery and Visual Science
• Fellow of the European Board of Ophthalmology
• Faculty member of the Microsurgical Skills Centre | Royal College of Ophthalmologists
• Member of the European Society of Cataract and Refractive Surgery
The eye is a truly amazing and wonderful organ providing us with vision, our most treasured sense. David is passionate about delivering excellence in surgical and medical care through excellence in clinical practice, research and teaching at national and international level.
David is a senior cataract, refractive and corneal surgeon at UHS NHS FT with more than 30 years’ experience of intraocular surgery. He has jointly led our International Cornea, Cataract and Refractive Surgery Fellowship training programme at UHS for over a decade, training surgeons from across the world in advanced surgical techniques.
David rained at St Thomas’ Hospital in London also undertaking elective medical training in neurology and neurosurgery at Harvard Medical School in Boston, USA. Following a position teaching anatomy at St Georges Hospital, I was appointed to positions in neurosurgery, then ophthalmology at St Bartholomew’s Hospital. David continued his training at Southampton Eye Hospital and won a Medical Research Grant to fund his PhD and was awarded a TFC Frost Scholarship to attend Bascom Palmer Eye institute in Miami, USA for one year. Completing his surgical training he was offered sequential full Fellowships in corneal, cataract and laser eye surgery at Moorfield Eye Hospital in London completing these in 2003 when he was appointed corneal, cataract and refractive surgeon in Southampton.
Research and publications
• Respected academic with over 100 peer reviewed publications in the scientific and medical literature.
• Landmark publications in high impact scientific and ophthalmology journals
• Author and co-author of 5 textbook chapters
• Numerous invited speaking engagements including keynote speaker
• Lead clinical investigator for research into astigmatism in cataract surgery, lens implant performance, and participation in large scale laser vision correction trials in LASIK and ASA
• Trainer for AMO VisX in wavefront laser vision correction across Europe
• Cited more than 3700 times across medical literature
• Examiner for European Board of Ophthalmology
David Anderson founded Anderson Eye Care in 2010 and is senior cataract, refractive and corneal surgeon at University Hospital Southampton with more than 30 years' experience of intraocular surgery. He has jointly led the fellowship training programme in cornea, cataract and refractive surgery at UHS for over a decade, training surgeons from across the world in advanced surgical techniques, led ophthalmology at UHS as clinical director from 2009 to 2012 and is head of the cataract surgery service. He has been successfully using the STAAR EVO ICL since 2007 in both refractive and therapeutic settings.
The eye is a truly amazing and wonderful organ providing us with vision, our most treasured sense and David is passionate about delivering excellence in surgical and medical care.
David trained at St Thomas' Hospital in London undertaking his elective medical training in neurology and neurosurgery at Harvard Medical School in Boston, USA. Following a position teaching anatomy at St Georges Hospital, he was appointed to positions in neurosurgery, then ophthalmology at St Bartholomew's Hospital. He continued his training at Southampton Eye Hospital and won a Medical Research Grant to fund his PhD followed by the award of TFC Frost Scholar to attend Bascom Palmer Eye institute in Miami, USA for one year. Completing his surgical training he was offered sequential full Fellowships in corneal, cataract and laser eye surgery at Moorfield Eye Hospital in London completing these in 2003 when he was appointed corneal, cataract and refractive surgeon in Southampton.
Academic achievements
· Respected academic with over 50 peer reviewed publications in the scientific and medical literature.
· Landmark publications in high impact scientific and ophthalmology journals
· Author and co-author of 5 textbook chapters
· Numerous invited speaking engagements including keynote speaker
· Lead clinical investigator for research into astigmatism in cataract surgery, lens implant performance, and participation in large scale laser vision correction trials in LASIK and ASA
· Cited more than 2800 times across medical literature
· PhD examiner for University of London
· Advisor to NICE
· Advisor to NIHR
· National Expert Advisory Group to Nuffield Health
Photos of David Anderson

Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.
Important Safety Information
The ICL is designed for the correction/reduction of myopia in patients, 21 to 60 years of age, ranging from -0.5 D to -20.0 D with or without astigmatism up to 6.0 D and the correction/reduction of hyperopia in patients, from 21 to 45 years of age, with hyperopia ranging from +0.5 D to +16.0 D with or without astigmatism up to 6.0 D. In order to be sure that your surgeon will use a ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.